𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines

✍ Scribed by Martin J. Edelman; Heather Quam; Brian Mullins


Publisher
Springer
Year
2001
Tongue
English
Weight
94 KB
Volume
48
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Vorinostat increases carboplatin and pac
✍ Taofeek K. Owonikoko; Suresh S. Ramalingam; Beatriz Kanterewicz; Trent E. Balius 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 533 KB

## Abstract We observed a 53% response rate in non‐small cell lung cancer (NSCLC) patients treated with vorinostat plus paclitaxel/carboplatin in a Phase I trial. Studies were undertaken to investigate the mechanism (s) underlying this activity. Growth inhibition was assessed in NSCLC cells by MTT